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Abstract Zf9/CPBP/KLF6 is a widely expressed member of
the Kru«ppel-like family of transcriptional factors which regulates
gene expression in hepatic stellate cells. Because of its ubiquitous
expression including in the esophagus, we have explored its
function in the esophageal squamous epithelium, a model system
to study cellular proliferation and differentiation. Reverse
transcription-PCR (RT-PCR) and Western blot analyses
revealed that Zf9 was highly expressed in human esophageal
squamous cancer cell lines. Additionally, Zf9 localizes to the
esophageal squamous epithelium by immunohistochemistry.
Using transient transfection, Zf9 transactivates the human
keratin 4 (K4) promoter reporter gene construct in a subset of
the esophageal cancer cell lines through indirect mechanisms.
Co-transfection of Zf9 and GKLF/KLF4, which is also a member
of the Kru«ppel-like factors and expressed in the esophageal
squamous epithelium, leads to coactivation in an additive fashion.
Furthermore, we demonstrate that there is a physical interaction
between GKLF and Zf9, a novel finding for Kru«ppel-like family
members.
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1. Introduction
Transcriptional factors are grouped into several classes,
which include the helix-loop-helix, leucine zipper, homeodo-
main, and zinc ¢nger protein families. Some zinc ¢nger tran-
scriptional factors can be further subclassi¢ed based on their
homology to the Drosophila Kru«ppel protein [1]. The Kru«p-
pel-like transcriptional factors so far cloned include erythroid
Kru«ppel-like factor (EKLF/KLF1), lung Kru«ppel-like factor
(LKLF/KLF2), basic Kru«ppel-like factor (BKLF/KLF3), gut-
enriched Kru«ppel-like factor (GKLF/KLF4), basic transcrip-
tion factor element binding protein 2 (BTEB2/KLF5), Zf9/
CPBP/KLF6, ubiquitous Kru«ppel-like factor (UKLF/KLF7),
fetal erythroid Kru«ppel-like factor (FKLF/KLF8), and basic
transcription factor element binding protein (BTEB1/KLF9).
The Zf9 gene was cloned originally from cDNA libraries of
activated rat stellate cells [2] and human placenta [3]. Zf9
contains three Cys2^His2 zinc ¢ngers in its carboxyl-terminal
domain and a unique amino-terminal domain that is rich in
serine/proline clusters, which could be potential targets for
post-translational modi¢cations. Rat zf9 mRNA displays
ubiquitous expression, with highest levels in lung and intes-
tine. Zf9 protein expression is accelerated after CCl4-induced
acute liver injury in rats [2]. Since Zf9 expression is induced in
activated stellate cells, it may be important in modulating
immediate early response genes. To date, targets of Zf9 in-
clude the collagen K1 (I) promoter [2] and the promoters of
the TGF-L types I and II receptors [4].
GKLF/KLF4 is also a member of the Kru«ppel-like tran-
scriptional factors, originally cloned from an NIH3T3 library
[5] and a primary mouse embryonic ¢broblast library [6].
GKLF mRNA expression is relatively ubiquitous, however,
there is correlation with expression in di¡erentiating cells or
di¡erentiated compartments. For example, GKLF is enriched
in epithelial cells located in the middle to upper crypt region
of the colonic epithelium [5]. GKLF is expressed in the supra-
basal compartment which is the early di¡erentiated region of
strati¢ed squamous epithelium found in the skin, tongue and
esophagus [6]. GKLF had higher expression in growth-ar-
rested ¢broblasts than in exponentially growing cells. Consti-
tutive expression of GKLF in COS-1 cells resulted in the in-
hibition of DNA synthesis [5] and the GKLF mRNA level
was signi¢cantly decreased in the small intestine of Min mice
compared to wild-type mice [7], suggesting that GKLF may
be a negative regulator of cell cycle progression.
The keratins are attractive models for investigating prolif-
eration and di¡erentiation in the strati¢ed squamous epitheli-
um [8]. While some keratins are ubiquitous, others are rela-
tively tissue restricted. For example, keratin 4 (K4) is highly
expressed in the esophageal and corneal squamous suprabasal
cells and its expression is associated with the switch from
proliferation to di¡erentiation [9]. K4 homozygous null mice
have a phenotype largely restricted to the esophagus and cor-
nea where there is impairment of the normal di¡erentiation
program [10]. Thus, K4 appears to be important in maintain-
ing the di¡erentiation phenotype in a highly tissue-speci¢c
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fashion. We have previously demonstrated that GKLF can
transactivate the human K4 promoter through the binding
to a CACCC motif [9]. Given the ubiquitous expression of
Zf9 and the presence of multiple GC motifs in the human K4
promoter, we sought to determine the role of Zf9 in the
esophageal squamous epithelium in regulating the early di¡er-
entiation linked K4 gene transcription and in this context,
identifying gene targets outside of stellate cells. We demon-
strate herein that Zf9 transactivates the K4 promoter and
there is an additive e¡ect on K4 promoter activity by
GKLF and Zf9. This may be mediated through physical in-
teraction between Zf9 and GKLF.
2. Materials and methods
2.1. Tissue culture
TE-2, TE-4, TE-8, TE-9, TE-11, TE-12, T.T, and T.Tn are esoph-
ageal cancer cell lines derived from human esophageal squamous cell
carcinomas and were grown in Dulbecco’s modi¢ed Eagle’s medium,
supplemented with 10% fetal bovine serum (Sigma, St. Louis, MO,
USA), 100 mg/ml streptomycin (Sigma), 100 units/ml penicillin (Sig-
ma), and L-glutamine (Life Technologies, Inc., Grand Island, NY,
USA) at 37‡C. HepG2 (liver cancer cell line), 3T3 (mouse ¢broblasts),
293 (human embryonic kidney cells), CaCO2 (colon cancer cell lines),
SaoS2 (osteosarcoma cell line), and SCC-13 (skin cancer cell line)
(ATCC, Manassas, VA, USA) were maintained under similar condi-
tions. OKF6 cells (primary human oral keratinocytes) were grown in
keratinocyte serum-free medium supplemented with a specialized
growth factor mixture (Life Technologies, Inc.). Primary human
skin keratinocytes (KPC) and human esophageal keratinocytes
(EPC) were grown as described previously [11]. Het1a cells (human
esophageal cells immortalized with SV40 large T antigen) were main-
tained in BRFF-EPM2 medium (Biological Research Faculty and
Facility, Inc., Ijamsville, MD, USA) as described previously [12].
2.2. DNA plasmids
The human K4 promoter reporter gene constructs (K4-1040, K4-
940, K4-740, K4-540, K4-340, K4-200, and K4-140) have been de-
scribed previously [13]. K4-105, K4-80, and K4-30 were generated
using K4-1040 as a template for PCR with sense primers as follows:
K4-105-S: 5P-GCG TCG ACT GTG CCA AGG CCA AGC CCA-3P ;
K4-80-S: 5P-GCG TCG ACT TTC AGA TTT TTC CCT TTA-3P ;
K4-30-S: 5P-GCG TCG ACA CAT ATA AGA GAC GAA GGC-3P.
The antisense primer sequence was as follows: 5P-GAA GAT CTG
GCT GCA GAG AGC GAG CTG-3P.
The SalI- and BglII-digested PCR products were ligated into the
luciferase reporter gene promoterless vector, pXP2.
A histidine/Xpress-tagged GKLF expression vector, pcDNA3.1-
HisB-GKLF, has been described previously [9]. A Zf9 expression
vector cloned into pCIneo (Promega Corp., Madison, WI, USA),
pCIneo-Zf9, was described previously [2]. All plasmids were puri¢ed
by a modi¢ed alkaline lysis method (Qiagen Inc., Valencia, CA,
USA).
2.3. Transfections
Transient transfection of all DNA constructs was performed by a
liposome mediated method using 4 Wl of lipofectamine and 6 Wl of
Plus reagent (Life Technologies, Inc.) containing 0.95 Wg total DNA.
Transfection e⁄ciency was monitored by using 0.2 Wg per plate of
pCMV-Lgal. Cells were harvested 48 h after transfection, washed
twice with ice-cold phosphate-bu¡ered saline (PBS), lysed in 200 Wl
of cell lysis reagent (Promega Corp.), and 100 Wl of lysate was mixed
with 100 Wl of luciferase assay reagent (Promega Corp.). Each experi-
ment was performed in triplicate and at least three sets of independent
transfections were performed. Luciferase activity was normalized to
L-galactosidase activity and the results were calculated as the mean þ
S.E.M. values for luciferase activity.
2.4. Reverse transcription-PCR (RT-PCR)
Oligonucleotide primers were designed to amplify the amino-termi-
nal region of the zf9 gene. The oligonucleotide primer sequences were
as follows: Zf9-S (sense): 5P-ATG GAT GTG CTC CCA ATG TGT
AGC ATC-3P Zf9-AS (antisense): 5P-GTT AAA ATG GCA CCG
ATG-3P. Total RNA was extracted as previously described [9] and
then reverse transcribed using Moloney murine leukemia virus
(MMLV) reverse transcriptase (Perkin-Elmer, Norwalk, CT, USA)
with random primers. Following a single cycle of reverse transcription
at 42‡C for 15 min, samples were subjected to 30 cycles of PCR (94‡C
for 1 min, 55‡C for 1 min, 72‡C for 1 min) using the Zf9-speci¢c
primers and the PCR products were electrophoresed on a 1% agarose
gel.
2.5. Immunoprecipitation and Western blotting
For detection of endogenously expressed Zf9 protein, lysates from
the cell lines were prepared in a bu¡er (ELB) containing 50 mM
HEPES (pH 7.0), 250 mM NaCl, 0.1% Nonidet P-40, 5 mM ethyl-
enediaminetetraacetate (EDTA), 1 mM phenylmethylsulfonyl £uoride
(PMSF), 1 mM dithiothreitol (DTT), and protease inhibitor tablets
(Roche Molecular Biochemicals, Indianapolis, IN, USA). Protein con-
centration was determined by the Bradford assay (Bio-Rad Labora-
tories, Richmond, CA, USA). Total protein samples (10 Wg/sample)
were separated on a 10% sodium dodecyl sulfate (SDS)^polyacryl-
amide gel and proteins were transferred to a polyvinylidene di£uoride
(PVDF) membrane (Immobilon-P, Millipore Corp., Bedford, MA,
USA). The membrane was blocked in 5% milk (Bio-Rad Laborato-
ries, Richmond, CA, USA) in 10 mM Tris^HCl (pH 8.0), 150 mM
NaCl, and 0.05% Tween-20 (1UTBST) for 1 h at room temperature
(RT). The membrane was incubated with primary polyclonal Zf9 anti-
body (R-173, Santa Cruz Biotechnology, Inc. Santa Cruz, CA, USA)
(1:500 in 1UTBST) overnight at 4‡C, followed by incubation with the
anti-rabbit horseradish peroxidase-conjugated secondary antibody
(Amersham Pharmacia Biotech, Inc. Piscataway, NJ, USA) (1:3000
in 1UTBST) for 1 h at RT. The signal was visualized by an enhanced
chemiluminescence solution (ECL Plus, Amersham Pharmacia Bio-
tech, Inc. Piscataway, NJ, USA) and exposed to Kodak-X-Omat LS
¢lm (Eastman Kodak Special Products Division, Rochester, NY,
USA).
For immunoprecipitation, TE-8 cells were harvested 48 h after co-
transfection of 0.5 Wg pCIneo-Zf9 and 0.5 Wg pcDNA3.1-HisB-
GKLF, washed three times with ice-cold PBS, scraped with a rubber
policeman into 1 ml of ELB bu¡er, transferred to microtubes, and
centrifuged at 14 000 rpm for 15 min at 4‡C. After the supernatant
was incubated with either 2 Wg of anti-Zf9 antibody (R-173) or anti-
Xpress antibody (Invitrogen, Carlsbad, CA, USA) for 1 h at 4‡C, 20 Wl
of protein A/G Plus agarose beads (Santa Cruz Biotechnology, Inc.)
were added to the lysates and incubated overnight at 4‡C. The beads
were subsequently washed three times with 500 Wl ELB bu¡er, solu-
bilized in SDS sample bu¡er (65 mM Tris, pH 6.8, 25% glycerol, 2%
SDS, and 5% L-mercaptoethanol), boiled, and subjected to SDS^
PAGE followed by Western blotting under the same conditions as
described above. As a negative control, immunoprecipitation was con-
ducted with control rabbit or mouse IgG (Sigma, St. Louis, MO,
USA). For detection of GKLF protein, anti-rabbit GKLF serum (a
gift from Dr. Vincent W. Yang) (1:2500 in 1UTBST) and anti-rabbit
horseradish peroxidase-conjugated antibody (Amersham Pharmacia
Biotech, Inc.) were used as the primary and secondary antibodies,
respectively. For detection of Zf9 protein, anti-Zf9 antibody (R-173)
(1:500 in 1UTBST) and anti-rabbit horseradish peroxidase-conju-
gated antibody (Amersham Pharmacia Biotech, Inc.) (1:3000 in
1UTBST) were used as the primary and secondary antibodies, respec-
tively. To con¢rm the speci¢city of our immunoprecipitation and
Western blot conditions, Western blot was performed with control
rabbit or mouse IgG.
2.6. Immunohistochemistry
Normal mouse esophageal tissue was ¢xed in 4% paraformaldehyde
and para⁄n embedded. Para⁄n sections were mounted on commer-
cially provided charged slides (ProbeOn Plus, Fisher Scienti¢c, Pitts-
burgh, PA, USA) and dried at 60‡C for 1 h. After routine dewaxing
and rehydration, the sections were soaked in 10 mM citric acid (pH
8.0) and heated in a microwave oven for 14 min for antigen retrieval.
Endogenous peroxidase activity was blocked by incubating the sec-
tions with methanol containing 1.5% hydrogen peroxide for 15 min at
RT. The sections were washed in PBS, treated with avidin and biotin
blocking solutions (Vector Laboratories Inc., Burlingame, CA, USA),
and incubated with protein blocking agent (Immunotech Inc., West-
brook, ME, USA). Subsequently, they were incubated with anti-Zf9
polyclonal antibody [2] (1:10 000 in PBS, 0.1% BSA, 0.2% Triton
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X-100) or control serum (Vector Laboratories Inc.) at the same dilu-
tions overnight at 4‡C. After rinsing with PBS, the sections were
incubated with biotinylated secondary antibody (1:200 in PBS, 0.1%
BSA, 0.2% Triton X-100) for 45 min at 37‡C and HRP-conjugated
ABC solution (Vector Laboratories, Inc.) was applied for 40 min at
RT. The peroxidase activity was developed with DAB solution (Vec-
tor Laboratories, Inc.). Counterstaining was done with hematoxylin.
3. Results
3.1. Zf9 expression in diverse cell types and normal esophagus
Since ubiquitous expression of rat zf9 mRNA in rat tissues
has been previously reported [2,3], we determined expression
of human zf9 mRNA in various cell lines by RT-PCR using
zf9-speci¢c primers. A 600 bp PCR product was detected in
all cell lines examined, including normal and transformed
esophageal cells (Fig. 1). Then we assayed Zf9 protein in
cell lines, including of human esophageal squamous cancer
origin, by Western blot analysis. We detected as expected a
single 46 kDa band corresponding to Zf9 in all cell lines
examined (Fig. 2), implying post-translational modi¢cation(s)
of Zf9 such as glycosylation or phosphorylation in vivo, since
in vitro translated Zf9 is approximately 32 kDa [2].
These data led us to determine the localization of Zf9 pro-
tein in normal murine esophageal tissue by an immunohisto-
chemical approach with an antigen retrieval technique [14]. As
shown in Fig. 3A, positive nuclear staining was predominantly
in the epithelium, although no speci¢c distribution was noted
in this compartment. By contrast, esophageal tissue incubated
with rabbit serum instead of anti-Zf9 antibody did not show
any nuclear staining except weak cytoplasmic signals in the
epithelium (Fig. 3B), suggesting cross-reactivity but con¢rm-
ing the speci¢city of the anti-Zf9 antibody. Collectively, the
Zf9 expression data implied that Zf9 may have a physiological
role in the esophagus, prompting us to explore its modulation
of transcriptional regulatory mechanisms.
3.2. Zf9 transactivates the full-length K4 promoter in TE-8 and
HepG2 cell lines
It has been shown previously that Zf9 can transactivate the
collagen K1 (I) promoter with two GC-rich regions [2] and the
promoters of the TGF-L types I and II receptors [4] in HepG2
and stellate cells. The K4 promoter is active in human esoph-
ageal cancer cell lines and contains some GC-rich elements
[13]. We therefore explored Zf9’s ability to in£uence K4 pro-
moter activity in the TE series of esophageal cancer cell lines
using the pCIneo-Zf9 expression vector, HepG2 cells served as
a control for Zf9 transactivation of genes. Transient trans-
fection of Zf9 showed signi¢cant transactivation of the full-
length K4-1040 promoter luciferase construct compared with
the empty expression vector (pCIneo) in TE-8 and HepG2 cell
lines, but not in TE-2, TE-4, TE-9, or TE-12 cell lines (Fig. 4).
This result indicates that Zf9 can transactivate the K4 pro-
moter restricted to a limited number of esophageal cancer cell
lines in spite of expression of endogenous Zf9, suggesting a
requirement of cellular context for the activation of the K4
promoter by Zf9.
3.3. Zf9 mediated transactivation of the K4 promoter may be
mediated through indirect e¡ects
In order to determine the regions which are responsible for
the transactivation of Zf9 in the K4 promoter, K4 promoter
deletion constructs were co-transfected with pCIneo-Zf9 in
TE-8 cells. Although the K4 promoter contains multiple po-
tential Zf9 binding sequences £anking 3815 and 3803, 3450
and 3440, 3278 and 3243, and 3229 and 3220, Zf9 could
consistently and surprisingly transactivate the K431040,
3940, 3740, 3540, 3340, 3200, and 3140 constructs about
4-fold compared with the pCIneo empty vector, indicating
that these GC-rich elements may not be preferred binding
sites for Zf9 (Fig. 5). In order to determine whether three
GC-rich regions between positions 3125 and 3116, 3102
and 388, and 360 and 340 could be pivotal elements for
Zf9 binding, we synthesized K43105, 380, and 330 con-
structs. The nearly 4-fold activation by Zf9 was attenuated
gradually in parallel with a decrease of basal K4 promoter
activity without an abrupt decrease in transactivation (Fig.
5). This result suggests that transactivation of the K4 pro-
moter by Zf9 in part might originate from an indirect e¡ect,
possibly mediated by a co-factor(s).
3.4. Additive e¡ect of Zf9 and GKLF on the K4 promoter
GKLF is a member of the Kru«ppel family of transcriptional
factors and has been shown to be expressed in the suprabasal
compartment of the esophageal squamous epithelium [6]. We
have previously reported that GKLF can transactivate the K4
promoter in 293 cells through direct binding of a CACACCC
motif between 3340 and 3140 nucleotides [9]. These facts
prompted us to investigate the combinatorial e¡ects of
GKLF and Zf9 on the K4 promoter in TE-8 cells. As shown
in Fig. 6, whereas Zf9 or GKLF expression vectors individu-
ally could transactivate the K4 promoter 4-fold, the combina-
Fig. 1. Zf9 mRNA expression in various cell lines. cDNAs from
TE-11, TE-12, NIH3T3, SaoS2, OKF6, Het1a, KPC, EPC, and
T.Tn cells (lanes 1^9) were ampli¢ed by PCR using zf9-speci¢c
primers to generate 600 bp products. Lane 10 has no DNA tem-
plate (negative control).
Fig. 2. Zf9 protein expression in various cell lines. Western blot of
lysates from TE-11, TE-12, T.Tn, HepG2, 293, CaCO2, SCC-13,
and OKF6 cells (lanes 1^8) was probed with anti-Zf9 antibody
(1:100 dilution). Equal loading of protein was con¢rmed with Pon-
ceau-S staining.
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tion of Zf9 and GKLF resulted in nearly 8-fold activation
compared with the empty expression vectors. It should be
noted that empty vectors were co-transfected with Zf9 and
GKLF to adjust the total amount of transfected DNA and
exclude the possibility of non-speci¢c binding of Zf9 or
GKLF to the CMV promoter. Overall, these results suggested
that Zf9 and GKLF might directly or indirectly cooperate in
transactivating the K4 promoter.
3.5. Physical interaction of Zf9 and GKLF in esophageal
squamous epithelial cells
As a next step, we sought to explore the mechanisms under-
lying how Zf9 and GKLF might cooperate. One possibility
was direct protein^protein interaction between Zf9 and
GKLF. To that end, immunoprecipitation followed by West-
ern blotting were performed after co-transfection of the Zf9
and histidine/Xpress-tagged GKLF expression vectors in TE-8
cells. Even though TE-8 cells expressed endogenous Zf9 (data
not shown), we transfected both Zf9 and GKLF expression
vectors to reproduce the same conditions as in Fig. 6. When
immunoprecipitation was conducted with anti-Xpress anti-
body and Western blotting was performed with anti-GKLF
serum, we could detect an expected 65 kDa band for GKLF
(58 kDa GKLF plus 7 kDa tag) and when anti-Zf9 antibody
was used in a similar way, a 46 kDa band corresponding to
Zf9 was detected, verifying both antibodies are appropriate
for immunoprecipitation under the experimental conditions
employed (Fig. 7 and data not shown). When cell lysates
were immunoprecipitated with anti-Zf9 antibody and blotted
with anti-GKLF serum, the speci¢c band corresponding to
GKLF (65 kDa) was appreciated (Fig. 7). When cell lysates
were immunoprecipitated with anti-Xpress antibody and blot-
ted with anti-Zf9 antibody, the speci¢c band corresponding to
Zf9 (46 kDa) was detected (data not shown). The speci¢city of
this interaction was veri¢ed by the use of control anti-rabbit
and mouse IgG as controls for immunoprecipitation and
Fig. 3. Zf9 is expressed in the esophageal epithelium. Zf9 protein
expression was examined in normal murine esophagus by immuno-
histochemistry using the anti-Zf9 antibody. Panel A is a representa-
tive section indicating Zf9 staining in nuclei (arrow) and also cyto-
plasm in the esophageal epithelium. Panel B shows a tissue section
with rabbit serum and no nuclear staining. (Both ¢gures at 400U
magni¢cation.)
Fig. 4. Zf9 transactivates the K4 promoter in TE-8 and HepG2
cells. Transient co-transfection of the Zf9 expression vector (0.25 Wg
pCIneo-Zf9) and the full-length K4 promoter luciferase reporter
construct (0.25 Wg K4-1040) was carried out in the indicated cell
lines and then assayed for luciferase activity. Experiments were per-
formed in triplicate and repeated at least three times in independent
experiments. Data represent means þ S.E.M.
Fig. 5. Transient co-transfection of the Zf9 expression vector and
the K4 promoter deletion constructs in TE-8 cells. The Zf9 expres-
sion vector (0.25 Wg pCIneo-Zf9) was transiently co-transfected with
0.25 Wg of the K4 promoter deletion constructs (K4-940, K4-740,
K4-540, K4-340, K4-200, K4-140, K4-105, K4-80, and K4-30) in
TE-8 cells. Experiments were performed in triplicate and repeated at
least three times in independent experiments. Data represent means
þ S.E.M.
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Western blotting (Fig. 7 and data not shown). This result
demonstrates that Zf9 and GKLF are able to interact.
4. Discussion
Zf9 is a member of the Kru«ppel-like transcriptional factors,
originally cloned from a cDNA library of activated rat hepatic
stellate cells. Its protein expression in stellate cells is induced
after acute liver injury [2]. The same factor, alternatively
named CPBP, was cloned from a cDNA library of human
placenta [3]. zf9 mRNA expression is nearly ubiquitous,
although cellular localization within tissue compartments
has not been reported to date.
GKLF is another fairly ubiquitously expressed member of
the Kru«ppel-like transcriptional factors. It has been shown
that GKLF is expressed in esophageal suprabasal cells and
transcriptionally activates the human K4 promoter which lo-
calizes to suprabasal cells as well and is important in the
transition from proliferation to di¡erentiation in this cell
type [3,9,10]. The transcriptional regulation of the K4 pro-
moter by GKLF is mediated through a CACC-like element.
Since there are multiple GC-rich elements in close proximity
of the GKLF binding site within the K4 promoter, we ex-
plored whether a GC-rich element binding transcription fac-
tor, such as Zf9, might further regulate the human K4 pro-
moter. All these observations led us to postulate that Zf9
might be expressed in the esophagus, and might have a pivotal
role in regulating a promoter which is involved in di¡erentia-
tion of esophageal basal cells.
RT-PCR using zf9-speci¢c primers revealed that Zf9
mRNA was ubiquitously expressed in cell lines derived from
human esophageal squamous carcinomas, immortalized hu-
man esophageal epithelial cells and primary human esopha-
geal keratinocytes. Western blot analysis demonstrated robust
Zf9 protein expression in these cell lines. Immunohistochem-
ical analysis in normal murine esophagus revealed that Zf9
was predominantly expressed in the epithelium and in the
nuclei of such cells, consistent with the notion that Zf9 is a
transcriptional factor [2^4].
To investigate the biological role of Zf9, we then deter-
mined the e¡ects of Zf9 upon the K4 promoter given the
presence of GC regions and the role of the K4 protein in
di¡erentiation. To date, it has been shown that Zf9 can trans-
activate a reporter construct containing six GC-rich elements
in Drosophila Schneider (S2) cells, the collagen K1 (I) pro-
moter [2], and promoters of the TGF-L types I and II recep-
tors [4]. Zf9 could transactivate the full-length K4 promoter
luciferase construct in TE-8 and HepG2 cell lines, but not in
TE-2, TE-4, TE-9, or TE-12 cell lines. This result suggests that
the human K4 promoter can be transactivated by Zf9 in a
limited number of esophageal squamous cancer cell lines,
where an adequate cellular context might be required. Alter-
natively, exogenous Zf9 might not be able to overcome the
e¡ects of endogenous Zf9 which might be already abundant
and saturates cognate DNA binding sites. Co-transfection of
Zf9 with a series of K4 promoter deletion constructs failed to
identify a region that might mediate Zf9 transactivation of the
K4 promoter. This raised the possibility of indirect e¡ects of
Zf9 on the K4 promoter.
We investigated whether the K4 promoter activity could be
a¡ected by simultaneous transfection of other Kru«ppel-like
factors, such as GKLF. Indeed, co-transfection of GKLF
and Zf9 expression vectors in TE-8 cells had an additive e¡ect
on K4 promoter activity, raising the possibility that Zf9 and
GKLF proteins might interact physically. We demonstrated
that Zf9 and GKLF do interact based upon co-transfections
followed by immunoprecipitation and Western blot analysis.
Nevertheless, the manner by which the Zf9^GKLF interaction
modulates K4 gene transcription is not clear. It is possible
that GKLF recruits Zf9 and this heterodimeric complex binds
DNA through GKLF. There might also be a more compli-
cated interplay between Zf9 and GKLF with Sp1 in regulating
gene transcription since both GKLF and Zf9 have been
shown to bind Sp1 [4,15].
Overall, the K4 promoter is a newly identi¢ed gene target of
Zf9 and underscores an important role for Zf9 in the squa-
Fig. 6. Zf9 and GKLF have an additive e¡ect on the K4 promoter.
The Zf9 expression vector (0.25 Wg pCIneo-Zf9) and histidine/
Xpress-tagged GKLF expression vector (0.25 Wg pcDNA3.1-HisB-
GKLF) were transiently co-transfected with the full-length K4 pro-
moter luciferase construct (0.25 Wg K4-1040). The total amount of
DNA was 0.5 Wg by co-transfecting with the empty vector, pCIneo
or pcDNA3.1-HisB. Experiments were performed in triplicate and
repeated at least three times in independent experiments. Data rep-
resent means þ S.E.M.
Fig. 7. Zf9 and GKLF proteins interact with each other. TE-8 cells
were harvested 24 h after transient co-transfection of pCIneo-Zf9
(0.5 Wg) and pcDNA3.1-HisB-GKLF (0.5 Wg) and immunoprecipi-
tated with either anti-Zf9 antibody or anti-Xpress antibody. The im-
munoprecipitated samples were subjected to SDS^PAGE followed
by Western blotting with anti-rabbit GKLF serum. The upper band
represent 65 kDa bands corresponding to histidine/Xpress-tag (7
kDa) and GKLF (58 kDa) and a lower band represents a product
of immunoglobulin heavy chains (HC). Control IgG did immuno-
precipitate either GKLF or Zf9.
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mous epithelium as illustrated in the esophagus. Furthermore,
Zf9 and GKLF interact physically and to our knowledge, this
is the ¢rst evidence of protein^protein interaction between
Kru«ppel-like transcription factors.
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